Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06613308
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-15
Brief Title:
Association Between Microbiome and the Efficacy and Safety of PD-1PD-L1 Blockade in Resectable NSCLC
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Association Between Respiratory Tract and Gut Microbiome and the Efficacy and Safety of PD-1PD-L1 Blockade in Resectable Non-small-cell Lung Cancer a Single-center Cohort Study
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will investigate the relationship between respiratory and gut microbiome and PD-1PD-L1 immune checkpoint inhibitor efficacy and immune-related adverse events irAE in patients with non-small cell lung cancer Stage IIA-IIIB
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None